Evidence map›Paper›PMID 31921413›Full record

ArticleAntimicrobial resistance and infection control2020

Infection prevention practices in the Netherlands: results from a National Survey.

Anita Huis, Jeroen Schouten, Dominique Lescure, Sarah Krein, David Ratz, Sanjay Saint, Marlies Hulscher, M Todd Greene

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Anita Huis1Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, PO box 9101 (114), 6500 HB Nijmegen, The Netherlands.ORCID 0000-0003-1144-163X
Jeroen Schouten1Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, PO box 9101 (114), 6500 HB Nijmegen, The Netherlands.
Dominique Lescure2Erasmus MC, University Medical Center Rotterdam, PO box 2040, 3000 CA Rotterdam, The Netherlands.
Sarah Krein3VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2800 Plymouth Road, North Campus Research Complex 16, Ann Arbor, MI 48109 USA.
David Ratz3VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2800 Plymouth Road, North Campus Research Complex 16, Ann Arbor, MI 48109 USA.
Sanjay Saint3VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2800 Plymouth Road, North Campus Research Complex 16, Ann Arbor, MI 48109 USA.
Marlies Hulscher1Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, PO box 9101 (114), 6500 HB Nijmegen, The Netherlands.
M Todd Greene3VA Ann Arbor Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2800 Plymouth Road, North Campus Research Complex 16, Ann Arbor, MI 48109 USA.
Radboud University Nijmegen · NLUniversity of Michigan · USErasmus MC · NLVA Ann Arbor Healthcare System · US

Funding

HSRD VA IK6 HX003399
6 · The paper itself

Abstract

Objective: To examine the extent to which acute care hospitals in the Netherlands have adopted recommended practices to prevent catheter-associated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), ventilator-associated pneumonia (VAP), and Methods: Between 18 July 2017 and 31 October 2017, we surveyed the infection prevention teams of all acute care hospitals in the Netherlands. The survey instrument was based on the 'Translating Healthcare-Associated Infection Prevention Research into Practice' (TRIP) questionnaire and adapted to the Dutch context. Descriptive statistics were used to examine the reported regular use of CAUTI, CLABSI, VAP, and CDI prevention practices as well as the hospital characteristics. Results: Out of 72 eligible hospitals, 47 (65.3%) responded. Surveillance systems for monitoring CAUTI, CLABSI, VAP, and CDI were present in 17.8, 95.4, 26.2, and 77.3% of hospitals, respectively. Antimicrobial stewardship programs have been established in 91.5% of participating hospitals. For CAUTI, the majority of hospitals regularly used aseptic technique during catheter insertion (95%) and portable bladder ultrasound scanners (86.1%). Intermittent catheterization and catheter stop-orders were regularly used by 65.8 and 62.2% of hospitals. For CLABSI, all hospitals regularly used maximum sterile barrier precautions and chlorhexidine gluconate for insertion site antisepsis. Avoidance of the femoral site for central line insertions was regularly used by 65.9% of hospitals. Urinary catheters and central-lines impregnated with antibiotics or antiseptics were rarely used (≤ 5%). Selective decontamination strategies for preventing VAP were used in 84% of hospitals. With the exception of disposable thermometers (31.8%), all prevention practices to prevent CDI were regularly used by more than 80% of hospitals. Conclusions: Most Dutch hospitals report regular use of recommended practices for preventing CLABSI and CDI. Several specific practices to prevent CAUTI and VAP were less frequently used, however, providing an opportunity for improvement.

Indexed as

Antimicrobial StewardshipCatheter-Related InfectionsClostridium InfectionsCross InfectionCross-Sectional StudiesHumansInfection ControlNetherlandsPneumonia, Ventilator-AssociatedPractice Guidelines as TopicSepsisSurveys and QuestionnairesUrinary Tract InfectionsHealthcare-associated infectionHospitalsImplementationInfection controlNosocomial

Identifiers

PMID31921413
PMCPMC6945725
OpenAlexW3001826093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.